Ariana Pharmaceuticals is proud to announce the publication of a new Real-World Evidence study: “eXp AI-driven Discovery of Genomic Biomarkers for Liver Toxicity Risk – A UK Biobank Case Study.” in The Pharmacogenomics Journal This research showcases how Ariana’s explainable Artificial Intelligence (eXp AI) and proprietary KEM® (Knowledge Extraction & Management) platform can identify genomic […]
